The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Anti–Methicillin-Resistant Staphylococcus aureus Nanoantibiotics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cs derivatives have been shown to interact with microbial cell membranes, resulting in a loss of membrane integrity (Labruère et al., 2019).”
From Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent (2024) · cites this paper as Labruère et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 1×
“Antibiotic resistance in disease-causing bacteria such as S. aureus has become a major medical issue not only because of their rise in incidence but also in their increasing degree of antibiotic resistance and lethality (Klevens et al., 2007).”
BackgroundBiodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Rujitanaroj, P.-O., Pimpha, N., & Supaphol, P. (2008) · Polymer · doi:10.1016/j.polymer.2008.08.021 · Cited by 527
Biocompatibility and drug delivery systems
Kohane, D. S., & Langer, R. (2010) · Chem. Sci. · doi:10.1039/c0sc00203h · Cited by 307
Research works printed but not linked: 204
- Abeylath, 2007, Glycosylated polyacrylate nanoparticles by emulsion polymerization, Carbohydr. Polym., 70, 32, 10.1016/j.carbpol.2007.02.027 · DOI
- Abeylath, 2008, Glyconanobiotics: novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis, Bioorg. Med. Chem., 16, 2412, 10.1016/j.bmc.2007.11.052 · doi:10.1016/j.bmc.2007.11.052
- Abeylath, 2009, Nanobiotics to combat bacterial drug resistance, 425
- Alt, 2004, An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement, Biomaterials, 25, 4383, 10.1016/j.biomaterials.2003.10.078 · DOI · Paper page
- Ansari, 2011, Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on isolates from skin infections, Biol. Med., 3, 141, 10.4172/0974-8369.10000100 · doi:10.4172/0974-8369.10000100
- Ansari, 2012, Characterization of clinical strains of MSSA, MRSA and MRSE isolated from skin and soft tissue infections and the antibacterial activity of ZnO nanoparticles, World J. Microbiol. Biotechnol., 28, 1605, 10.1007/s11274-011-0966-1 · DOI
- Ayala-Núñez, 2009, Silver nanoparticles toxicity and bactericidal effect against methicillin-resistant Staphylococcus aureus: nanoscale Does Matter, Nanobiotechnology, 5, 2, 10.1007/s12030-009-9029-1 · DOI · Paper page
- Bagchi, 2012, Antimicrobial efficacy and biocompatibility study of copper nanoparticle adsorbed mullite aggregates, Mater. Sci. Eng. C, 32, 1897, 10.1016/j.msec.2012.05.011 · DOI
- Balogh, 2001, Dendrimer–silver complexes and nanocomposites as antimicrobial agents, Nano Lett., 1, 18, 10.1021/nl005502p · DOI · Paper page
- Bandow, 2009, New ways of killing the beast: prospects for inorganic–organic hybrid nanomaterials as antibacterial agents, ChemBioChem, 10, 2847, 10.1002/cbic.200900628 · DOI
- Barber, 1961, Methicillin-resistant staphylococci, J. Clin. Pathol., 14, 385, 10.1136/jcp.14.4.385 · DOI · Paper page
- Blanco, 2015, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol., 33, 941, 10.1038/nbt.3330 · DOI · Paper page
- Bombelli, 2008, New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases, Mol. Pharm., 5, 672, 10.1021/mp800037d · doi:10.1021/mp800037d
- Brandt, 2012, Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine, Nanomed. Nanotech. Biol. Med., 8, 478, 10.1016/j.nano.2011.07.005 · DOI
- Bresee, 2011, Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles, Small, 7, 2027, 10.1002/smll.201100420 · doi:10.1002/smll.201100420
- Brown, 2012, Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus, Appl. Environ. Microbiol., 78, 2768, 10.1128/AEM.06513-11 · DOI · Paper page
- Buhleier, 1978, Cascade- and nonskid-chain-like syntheses of molecular cavity topologies, Synthesis, 2, 155, 10.1055/s-1978-24702 · DOI · Paper page
- Cevher, 2006, Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres, Int. J. Pharm., 317, 127, 10.1016/j.ijpharm.2006.03.014 · DOI
- Chaloupka, 2010, Nanosilver as a new generation of nanoproduct in biomedical applications, Trends Biotechnol., 28, 580, 10.1016/j.tibtech.2010.07.006 · DOI · Paper page
- Chambers, 1997, Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications, Clin. Microbiol. Rev. Rev., 10, 781, 10.1128/CMR.10.4.781 · DOI · Paper page
- Chen, 2008, Functional Fe3O4/TiO2 core/shell magnetic nanoparticles as photokilling agents for pathogenic bacteria, Small, 4, 485, 10.1002/smll.200701164 · DOI · Paper page
- Cheng, 2008, External electrostatic interaction versus internal encapsulation between cationic dendrimers and negatively charged drugs: which contributes more to solubility enhancement of the drugs, J. Phys. Chem. B, 112, 8884, 10.1021/jp801742t · DOI
- Choi, 2012, Photosensitizer and vancomycin-conjugated novel multifunctional magnetic particles as photoinactivation agents for selective killing of pathogenic bacteria, Chem. Commun., 48, 4591, 10.1039/c2cc17766h · DOI
- Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- Crossley, 2009, Staphylococci in human disease, 10.1002/9781444308464 · DOI
- Dallas, 2010, Magnetically controllable silver nanocomposite with multifunctional phosphotriazine matrix and high antimicrobial activity, Adv. Funct. Mater., 20, 2347, 10.1002/adfm.200902370 · DOI
- Dallas, 2011, Silver polymeric nanocomposites as advanced antimicrobial agents: classification, synthetic paths, applications, and perspectives, Adv. Colloid Interface Sci., 166, 119, 10.1016/j.cis.2011.05.008 · DOI · Paper page
- Dancer, 2008, The effect of antibiotics on methicillin-resistant Staphylococcus aureus, J. Antimicrob. Chemother., 61, 246, 10.1093/jac/dkm465 · DOI
- Daraee, 2016, Application of liposomes in medicine and drug delivery, Artif. Cells, Nanomed. Biotechnol., 44, 381, 10.3109/21691401.2014.953633 · DOI · Paper page
- Deresinski, 2005, Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey, Clin. Infect. Dis., 40, 562, 10.1086/427701 · DOI · Paper page
- Dinges, 2000, Exotoxins of Staphylococcus aureus, Clin. Microbiol. Rev., 13, 16, 10.1128/CMR.13.1.16 · DOI · Paper page
- Djokić, 2004, Deposition of silver oxysalts and their antimicrobial properties, J. Electrochem. Soc., 151, C359, 10.1149/1.1723498 · doi:10.1149/1.1723498
- Dospivova, 2012, Electrochemical behaviour of apoferritin encapsulating of silver(I) ions and its application for treatment of Staphylococcus aureus, Int. J. Electrochem. Sci., 7, 6378, 10.1016/S1452-3981(23)19488-0 · doi:10.1016/s1452-3981(23)19488-0
- Dugal, 2011, A novel strategy to control emerging drug resistant infections, J. Chem. Pharm. Res., 3, 584
- Dunnill, 2011, Nanoparticulate silver coated-titania thin films—photo-oxidative destruction of stearic acid under different light sources and antimicrobial effects under hospital lighting conditions, J. Photochem. Photobiol. A Chem., 220, 113, 10.1016/j.jphotochem.2011.04.001 · DOI
- Durairaj, 2010, Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin, Investig. Ophthalmol. Vis. Sci., 51, 5804, 10.1167/iovs.10-5388 · DOI
- Durán, 2008, Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3- hydroxyvalerate), Arch. Pharm. Res., 31, 1509, 10.1007/s12272-001-2137-7 · DOI
- Durán, 2016, Silver Nanoparticles: a new view on mechanistic aspects on antimicrobial activity, Nanomed. Nanotech. Biol. Med., 12, 789, 10.1016/j.nano.2015.11.016 · DOI · Paper page
- Edmiston, 2010, Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device, Am. J. Infect. Control., 38, 421, 10.1016/j.ajic.2009.09.010 · doi:10.1016/j.ajic.2009.09.010
- Elkhawass, 2014, Acute toxicity of different sizes of silver nanoparticles intraperitonally injected in BALB/c mice using two toxicological methods, Int. J. Pharm. Pharm. Sci., 7, 94
- Ellington, 2003, Intracellular Staphylococcus Aureus: a mechanism for the indolence of osteomyelitis, J. Bone Jt. Surg., 85, 918, 10.1302/0301-620X.85B6.13509 · DOI
- Ellington, 2006, Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis, J. Orthop. Res., 24, 87, 10.1002/jor.20003 · DOI
- Engler, 2012, Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections, Nano Today, 7, 201, 10.1016/j.nantod.2012.04.003 · DOI · Paper page
- Esmaeili, 2007, Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles, Nanomed. Nanotech. Biol. Med., 3, 161, 10.1016/j.nano.2007.03.003 · DOI
- Faraji, 2009, Nanoparticles in cellular drug delivery, Bioorg. Med. Chem., 17, 2950, 10.1016/j.bmc.2009.02.043 · DOI · Paper page
- Feng, 2000, A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus, J. Biomed. Mater. Res., 52, 662, 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 · DOI · Paper page
- Ferro, 2006, Inactivation of methicillin-resistant Staphylococcus aureus (MRSA) by liposome-delivered photosensitising agents, J. Photochem. Photobiol. B Biol., 83, 98, 10.1016/j.jphotobiol.2005.12.008 · doi:10.1016/j.jphotobiol.2005.12.008
- Ferro, 2007, Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome, Int. J. Biochem. Cell Biol., 39, 1026, 10.1016/j.biocel.2007.02.001 · DOI
- Ferro, 2009, Inclusion of 5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenylporphine in supramolecular aggregates of cationic amphiphilic cyclodextrins: physicochemical characterization of the complexes and strengthening of the antimicrobial photosensitizing activity, Biomacromolecules, 10, 2592, 10.1021/bm900533r · DOI
- Friedman, 2011, Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide - Biol. Chem., 25, 381, 10.1016/j.niox.2011.09.001 · DOI
- Gao, 2017, Toxicity of nano- and ionic silver to embryonic stem cells: a comparative toxicogenomic study, J. Nanobiotech., 15, 31, 10.1186/s12951-017-0265-6 · DOI
- Garay-Jimenez, 2011, A convenient method to prepare emulsified polyacrylate nanoparticles from for drug delivery applications, Bioorg. Med. Chem. Lett., 21, 4589, 10.1016/j.bmcl.2011.05.104 · doi:10.1016/j.bmcl.2011.05.104
- Garay-Jimenez, 2008, Methods for purifying and detoxifying sodium dodecyl sulfate–stabilized polyacrylate nanoparticles, Nanomed. Nanotech. Biol. Med., 4, 98, 10.1016/j.nano.2008.03.004 · DOI
- Garay-Jimenez, 2009, Physical properties and biological activity of poly(butyl acrylate–styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants, Nanomed. Nanotech. Biol. Med., 5, 443, 10.1016/j.nano.2009.01.015 · doi:10.1016/j.nano.2009.01.015
- Gillies, 2005, Dendrimers and dendritic polymers in drug delivery, Drug Discov. Today, 10, 35, 10.1016/S1359-6446(04)03276-3 · DOI · Paper page
- Gil-Tomás, 2011, Lethal photosensitisation of bacteria using a tin chlorin E6–glutathione–gold nanoparticle conjugate, J. Mater. Chem., 21, 4189, 10.1039/c0jm03555f · doi:10.1039/c0jm03555f
- Gliga, 2014, Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release, Part. Fibre. Toxicol., 11, 10.1186/1743-8977-11-11 · DOI · Paper page
- Golubeva, 2011, Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics, Glas. Phys. Chem., 37, 78, 10.1134/S1087659611010056 · DOI
- Goodyear, 2003, Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin, J. Exp. Med., 197, 1125, 10.1084/jem.20020552 · DOI · Paper page
- Greenhalgh, 2009, In vivo studies of polyacrylate nanoparticle emulsions for topical and systemic applications, Nanomed. Nanotech. Biol. Med., 5, 46, 10.1016/j.nano.2008.07.004 · DOI
- Guhagarkar, 2009, Nanoparticles of polyethylene sebacate: a new biodegradable polymer, AAPS Pharm. Sci. Tech., 10, 935, 10.1208/s12249-009-9284-4 · DOI
- Guo, 2010, Rose bengal–decorated silica nanoparticles as photosensitizers for inactivation of gram-positive bacteria, Nanotechnology, 21, 1, 10.1088/0957-4484/21/6/065102 · doi:10.1088/0957-4484/21/6/065102
- Guzman, 2012, Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria, Nanomed. Nanotech. Biol. Med., 8, 37, 10.1016/j.nano.2011.05.007 · DOI · Paper page
- Hackenberg, 2011, Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells, Toxicol. Lett., 201, 27, 10.1016/j.toxlet.2010.12.001 · DOI · Paper page
- Han, 2009, Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection, PLoS One, 4, 1, 10.1371/journal.pone.0007804 · DOI
- Hess, 2003, Intracellular survival of Staphylococcus aureus within cultured enterocytes, J. Surg. Res., 114, 42, 10.1016/S0022-4804(03)00314-7 · DOI
- Holtz, 2010, Development of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agent, Nanotechnology, 21, 1, 10.1088/0957-4484/21/18/185102 · DOI
- Holtz, 2012, Nanostructured silver vanadate as a promising antibacterial additive to water-based paints, Nanomed. Nanotech. Biol. Med., 8, 935, 10.1016/j.nano.2011.11.012 · DOI
- Huang, 2007, Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria, Nanomedicine, 88, 548, 10.2217/17435889.2.6.777 · DOI · Paper page
- Huang, 2009, γ-Ray assisted synthesis of silver nanoparticles in chitosan solution and the antibacterial properties, Chem. Eng. J., 155, 499, 10.1016/j.cej.2009.07.040 · doi:10.1016/j.cej.2009.07.040
- Huang, 2010, Sucrose ester micellar-mediated synthesis of Ag nanoparticles and the antibacterial properties, Colloids Surf. A Physicochem. Eng. Asp., 353, 69, 10.1016/j.colsurfa.2009.10.023 · DOI
- Huang, 2011, Eradication of drug Resistant Staphylococcus aureus by liposomal oleic acids, Biomaterials, 32, 214, 10.1016/j.biomaterials.2010.08.076 · DOI · Paper page
- Huang, 2011, Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections, Antimicrob. Agents Chemother., 55, 3432, 10.1128/AAC.01803-10 · DOI · Paper page
- Huh, 2011, “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, J. Control. Release, 156, 128, 10.1016/j.jconrel.2011.07.002 · DOI · Paper page
- Inoue, 2009, Antibacterial properties of nanostructured silver titanate thin films formed on a titanium plate, J. Biomed. Mater. Res. A, 92, 1171, 10.1002/jbm.a.32456 · doi:10.1002/jbm.a.32456
- Jain, 2010, Poly propyl ether imine (PETIM) dendrimer: a novel non-toxic dendrimer for sustained drug delivery, Eur. J. Med. Chem., 45, 4997, 10.1016/j.ejmech.2010.08.006 · doi:10.1016/j.ejmech.2010.08.006
- Jaspreet, 2005, Nanosystems in drug targeting: opportunities and challenges, Curr. Nanosci., 1, 48, 10.2174/1573413052953110 · DOI · Paper page
- Jevon, 1999, Mechanisms of internalization of Staphylococcus aureus by cultured human osteoblasts, Infect Immun., 67, 2677, 10.1128/IAI.67.5.2677-2681.1999 · DOI · Paper page
- Jevons, 1961, “Celbenin”-resistant staphylococci, Br. Med. J., 1, 124, 10.1136/bmj.1.5219.124-a · DOI · Paper page
- Jiang, 2012, Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits, Inflamm. Res., 61, 207, 10.1007/s00011-011-0402-x · DOI
- Jones, 2008, Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms, FEMS Microbiol. Lett., 279, 71, 10.1111/j.1574-6968.2007.01012.x · DOI · Paper page
- Josefsson, 2005, The surface protein Pls of methicillin-resistant Staphylococcus aureus is a virulence factor in septic arthritis, Society, 73, 2812, 10.1128/IAI.73.5.2812-2817.2005 · doi:10.1128/iai.73.5.2812-2817.2005
- Kangwansupamonkon, 2009, Antibacterial Effect of Apatite-Coated Titanium Dioxide for Textiles Applications, Nanomed. Nanotech. Biol. Med., 5, 240, 10.1016/j.nano.2008.09.004 · DOI · Paper page
- Kathiresan, 2009, Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment, Colloids Surf. B Biointerfaces, 71, 133, 10.1016/j.colsurfb.2009.01.016 · DOI · Paper page
- Kawata, 2009, In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells, Env. Sci. Tech., 43, 6046, 10.1021/es900754q · DOI · Paper page
- Kesharwani, 2017, Dendrimers in targeting and delivery of drugs, 363
- Kilian, 2011, Antimicrobial activity of liposome encapsulated cyclo(l-tyrosyl-l-prolyl), Pharmazie, 66, 421, 10.1691/ph.2011.0352 · doi:10.1691/ph.2011.0352
- Kim, 2010, Subchronic oral toxicity of silver nanoparticles, Part. Fibre. Toxicol., 7, 20, 10.1186/1743-8977-7-20 · DOI · Paper page
- Kim, 2013, Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles, Nanotoxicology, 7, 953, 10.3109/17435390.2012.676099 · DOI
- Kreuter, 1991, Nanoparticle-based drug delivery systems, J. Control. Release, 16, 169, 10.1016/0168-3659(91)90040-K · DOI · Paper page
- Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001 · DOI · Paper page
- Kuo, 2009, Antimicrobial gold nanorods with dual-modality photodynamic inactivation and hyperthermia, Chem. Commun., 32, 4853, 10.1039/b907274h · DOI
- Kvítek, 2008, Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs), J. Phys. Chem. C, 112, 5825, 10.1021/jp711616v · DOI · Paper page
- Kvitek, 2011, Antibacterial activity and toxicity of silver—nanosilver versus ionic silver, J. Phys. Conf. Ser., 304, 12, 10.1088/1742-6596/304/1/012029 · DOI
- Labruère, 2010, Poly(vinyl benzoate) nanoparticles for molecular delivery: studies on their preparation and in vitro properties, J. Control. Release, 148, 234, 10.1016/j.jconrel.2010.08.016 · DOI
- Lankveld, 2010, The kinetics of the tissue distribution of silver nanoparticles of different sizes, Biomaterials, 31, 8350, 10.1016/j.biomaterials.2010.07.045 · DOI · Paper page
- Le, 2010, Photochemical synthesis of highly bactericidal silver nanoparticles, Nanotech. Russ., 5, 554, 10.1134/S1995078010070177 · DOI
- Lee, 2010, Comparison of the efficacies of silver-containing dressing materials for treating a full-thickness rodent wound infected by methicillin-resistant Staphylococcus aureus, Korean J. Lab. Med., 30, 20, 10.3343/kjlm.2010.30.1.20 · doi:10.3343/kjlm.2010.30.1.20
- Leid, 2012, In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria, J. Antimicrob. Chemother., 67, 138, 10.1093/jac/dkr408 · DOI · Paper page
- Li, 2014, Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria, ACS Nano, 8, 10682, 10.1021/nn5042625 · DOI · Paper page
- Liao, 2014, A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin, J. Am. Chem. Soc., 136, 5896, 10.1021/ja502011g · DOI · Paper page
- Liau, 1997, Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions, Lett. Appl. Microbio., 25, 279, 10.1046/j.1472-765X.1997.00219.x · DOI · Paper page
- Liu, 2009, Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent, Nat. Nanotechnol., 4, 457, 10.1038/nnano.2009.153 · DOI · Paper page
- Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
- Lowy, 2000, Is Staphylococcus aureus an intracellular pathogen, Trends Microbiol., 8, 341, 10.1016/S0966-842X(00)01803-5 · DOI · Paper page
- Lu, 2010, Effect of surface coating on the toxicity of silver nanomaterials on human skin keratinocytes, Chem. Phys. Lett., 487, 92, 10.1016/j.cplett.2010.01.027 · DOI · Paper page
- Lukowski, 2008, Inhibition of dermal MRSA colonization by microalgal micro- and nanoparticles, Skin Pharmacol. Physiol., 21, 98, 10.1159/000113066 · DOI
- Madhumathi, 2010, Development of novel chitin/nanosilver composite scaffolds for wound dressing applications, J. Mater. Sci. Mater. Med., 21, 807, 10.1007/s10856-009-3877-z · DOI · Paper page
- Majdalawieh, 2014, Recent advances in gold and silver nanoparticles: synthesis and applications, J. Nanosci. Nanotechnol., 14, 4757, 10.1166/jnn.2014.9526 · DOI · Paper page
- Maki, 2010, In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection, Clin. Infect. Dis., 50, 1580, 10.1086/652764 · DOI
- Martinez, 2009, Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection, J. Invest. Dermatol., 129, 2463, 10.1038/jid.2009.95 · DOI · Paper page
- Martins, 2010, Antitumoral activity of L-ascorbic acid-poly-D,L-(lactide-co-glycolide) nanoparticles containing violacein, Int. J. Nanomedicine, 5, 77, 10.2147/IJN.S7833 · DOI
- Matthews, 2010, Applications of nanomedicine in antibacterial medical therapeutics and diagnostics, Open Trop. Med. J., 3, 1, 10.2174/18743153010030100001 · DOI
- McCaig, 2006, Staphylococcus aureus–associated skin and soft tissue infections in ambulatory care, Emerg. Infect. Dis., 12, 1715, 10.3201/eid1211.060190 · DOI · Paper page
- Mei, 2014, Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG, Int. J. Pharm., 468, 26, 10.1016/j.ijpharm.2014.04.008 · DOI
- Meng, 2009, Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting MecA, Antimicrob. Agents Chemother., 53, 2871, 10.1128/AAC.01542-08 · DOI
- Mikklesen, 2011, Survey on basic knowledge about exposure and potential environmental and health risks for selected nanomaterials
- Mora-Huertas, 2010, Polymer-based nanocapsules for drug delivery, Int. J. Pharm., 385, 113, 10.1016/j.ijpharm.2009.10.018 · DOI · Paper page
- Moritz, 2013, The newest achievements in synthesis, immobilization and practical applications of antibacterial nanoparticles, Chem. Eng. J., 228, 596, 10.1016/j.cej.2013.05.046 · DOI · Paper page
- Nabikhan, 2010, Synthesis of antimicrobial silver nanoparticles by callus and leaf extracts from saltmarsh plant, Sesuvium portulacastrum L., Eng. Asp., 79, 488, 10.1016/j.colsurfb.2010.05.018 · DOI · Paper page
- Nanda, 2009, Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE, Nanomed. Nanotech. Biol. Med., 5, 452, 10.1016/j.nano.2009.01.012 · DOI · Paper page
- Necula, 2009, In vitro antibacterial activity of porous TiO2–Ag composite layers against methicillin-resistant Staphylococcus aureus, Acta Biomater., 5, 3573, 10.1016/j.actbio.2009.05.010 · doi:10.1016/j.actbio.2009.05.010
- Nederberg, 2011, Biodegradable nanostructures with selective lysis of microbial membranes, Nat. Chem., 3, 409, 10.1038/nchem.1012 · DOI · Paper page
- Nirmala, 2011, Synthesis and characterization of bovine femur bone hydroxyapatite containing silver nanoparticles for the biomedical applications, J. Nanoparticle Res., 13, 1917, 10.1007/s11051-010-9944-z · DOI
- Norrby, 2005, Lack of development of new antimicrobial drugs: a potential serious threat to public health, Lancet Infect. Dis., 5, 115, 10.1016/S1473-3099(05)70086-4 · doi:10.1016/s1473-3099(05)70086-4 · Paper page
- Onyeji, 1994, Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin, Infection, 22, 338, 10.1007/BF01715542 · DOI
- Pal, 2009, Synthesis of highly antibacterial nanocrystalline trivalent silver polydiguanide, J. Am. Chem. Soc., 131, 16147, 10.1021/ja9051125 · DOI
- Panacek, 2006, Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity, J. Phys. Chem. B, 110, 16248, 10.1021/jp063826h · DOI · Paper page
- Pangule, 2010, Anti-staphylococcal nanocomposite films based on enzyme–nanotube conjugates, ACS Nano, 4, 3993, 10.1021/nn100932t · DOI
- Park, 2013, Toxicokinetic differences and toxicities of silver nanoparticles and silver ions in rats after single oral administration, J. Toxicol. Environ. Health A, 76, 1246, 10.1080/15287394.2013.849635 · DOI
- Park, 2011, Size dependent macrophage responses and toxicological effects of Ag nanoparticles, Chem. Commun., 47, 4382, 10.1039/c1cc10357a · DOI · Paper page
- Park, 2011, Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats, Arch. Pharm. Res., 34, 153, 10.1007/s12272-011-0118-z · DOI · Paper page
- Park, 2011, The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles, Biomaterials, 32, 9810, 10.1016/j.biomaterials.2011.08.085 · DOI · Paper page
- Perelshtein, 2012, Enzymatic pre-treatment as a means of enhancing the antibacterial activity and stability of ZnO nanoparticles sonochemically coated on cotton fabrics, J. Mater. Chem., 22, 10736, 10.1039/c2jm31054f · DOI
- Perni, 2009, The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles, Biomaterials, 30, 89, 10.1016/j.biomaterials.2008.09.020 · DOI · Paper page
- Perni, 2011, Nanoparticles: their potential use in antibacterial photodynamic therapy, Photochem. Photobiol. Sci., 10, 712, 10.1039/c0pp00360c · DOI · Paper page
- Pinto-Alphandary, 2000, Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications, Int. J. Antimicrob. Agents, 13, 155, 10.1016/S0924-8579(99)00121-1 · DOI · Paper page
- Pissuwan, 2010, Functionalised gold nanoparticles for controlling pathogenic bacteria, Trends Biotechnol., 28, 207, 10.1016/j.tibtech.2009.12.004 · DOI · Paper page
- Pornpattananangkul, 2011, Bacterial toxin–triggered drug release from gold nanoparticle–stabilized liposomes for the treatment of bacterial infection, J. Am. Chem. Soc., 133, 4132, 10.1021/ja111110e · DOI · Paper page
- Potempa, 2009, Corruption of innate immunity by bacterial proteases, J. Innate Immun., 1, 70, 10.1159/000181144 · DOI · Paper page
- Prucek, 2011, The targeted antibacterial and antifungal properties of magnetic nanocomposite of iron oxide and silver nanoparticles, Biomaterials, 32, 4704, 10.1016/j.biomaterials.2011.03.039 · DOI · Paper page
- Pumerantz, 2011, Preparation of liposomal vancomycin and intracellular killing of methicillin-resistant Staphylococcus aureus (MRSA), Int. J. Antimicrob. Agents, 37, 140, 10.1016/j.ijantimicag.2010.10.011 · DOI
- Quang Huy, 2013, Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives, Adv. Nat. Sci., 4, 1, 10.1088/2043-6262/4/3/033001 · DOI · Paper page
- Raghunandan, 2011, Microwave-assisted rapid extracellular biosynthesis of silver nanoparticles using carom seed (Trachyspermum copticum) extract and in vitro studies, Am. J. Anal. Chem., 2, 475, 10.4236/ajac.2011.24057 · DOI
- Raghupathi, 2011, Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles, Langmuir, 27, 4020, 10.1021/la104825u · DOI · Paper page
- Rai, 2009, Silver nanoparticles as a new generation of antimicrobials, Biotechnol. Adv., 27, 76, 10.1016/j.biotechadv.2008.09.002 · DOI · Paper page
- Rathnayake, 2012, Synthesis and characterization of nano silver based natural rubber latex foam for imparting antibacterial and anti-fungal properties, Polym. Test., 31, 586, 10.1016/j.polymertesting.2012.01.010 · DOI
- Ray, 2005, In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(ε-caprolactone) microparticles, Antimicrob. Agents Chemother., 49, 3025, 10.1128/AAC.49.7.3025-3027.2005 · doi:10.1128/aac.49.7.3025-3027.2005
- Ren, 2009, Characterisation of copper oxide nanoparticles for antimicrobial applications, Int. J. Antimicrob. Agents, 33, 587, 10.1016/j.ijantimicag.2008.12.004 · DOI · Paper page
- Roy, 2010, Effect of nano–titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus Aureus, J. Biomater. Nanobiotechnol., 1, 37, 10.4236/jbnb.2010.11005 · doi:10.4236/jbnb.2010.11005
- Samberg, 2010, Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro, Environ. Health Perspect., 118, 407, 10.1289/ehp.0901398 · DOI · Paper page
- Samberg, 2011, Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods, Nanotoxicology, 5, 244, 10.3109/17435390.2010.525669 · DOI
- Sande, 2012, Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model, J. Antimicrob. Chemother., 67, 2191, 10.1093/jac/dks212 · DOI
- Saravanan, 2010, Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE, Colloids Surf. B Biointerfaces, 77, 214, 10.1016/j.colsurfb.2010.01.026 · doi:10.1016/j.colsurfb.2010.01.026
- Schairer, 2012, Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses, Virulence, 3, 62, 10.4161/viru.3.1.18816 · DOI
- Scoville, 2017, Genetic determinants of susceptibility to silver nanoparticle–induced acute lung inflammation in mice, Fed. Am. Soc. Exper. Biolog J., 31, 4600, 10.1096/fj.201700187R · DOI
- Sekhon, 2010, Inorganic nanomedicine—part 1, Nanomed. Nanotech. Biol. Med., 6, 516, 10.1016/j.nano.2010.04.004 · doi:10.1016/j.nano.2010.04.004
- Sekhon, 2010, Inorganic nanomedicine—part 2, Nanomed. Nanotech. Biol. Med., 6, 612, 10.1016/j.nano.2010.04.003 · DOI
- Shameli, 2010, Green synthesis of silver/montmorillonite/chitosan bionanocomposites using the UV irradiation method and evaluation of antibacterial activity, Int. J. Nanomedicine, 5, 875, 10.2147/IJN.S13632 · doi:10.2147/ijn.s13632
- Shameli, 2011, Fabrication of silver nanoparticles doped in the zeolite framework and antibacterial activity, Int. J. Nanomedicine, 6, 331, 10.2147/IJN.S16964 · doi:10.2147/ijn.s16964
- Shameli, 2011, Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity, Int. J. Nanomedicine, 6, 271, 10.2147/IJN.S16043 · DOI · Paper page
- Sharma, 2009, Silver nanoparticles: green synthesis and their antimicrobial activities, Adv. Colloid Interface Sci., 145, 83, 10.1016/j.cis.2008.09.002 · DOI · Paper page
- Shastri, 2012, Antimicrobial activity of nanosilver-coated socks fabrics against foot pathogens, J. Text. Inst., 103, 1234, 10.1080/00405000.2012.675680 · DOI
- Sibbald, 2006, Mapping the pathways to staphylococcal pathogenesis by comparative secretomics, Microbiol. Mol. Biol. Rev., 70, 755, 10.1128/MMBR.00008-06 · DOI · Paper page
- Singh, 2012, Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles, Toxicol. Lett., 213, 249, 10.1016/j.toxlet.2012.07.009 · DOI · Paper page
- Son, 2007, Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 1. Drug/gene delivery applications, Drug Discov. Today, 12, 650, 10.1016/j.drudis.2007.06.002 · DOI · Paper page
- Son, 2007, Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 2: imaging, diagnostic, and therapeutic applications, Drug Discov. Today, 12, 657, 10.1016/j.drudis.2007.06.012 · DOI
- Stevanović, 2012, Poly(lactide-co-glycolide)/silver nanoparticles: synthesis, characterization, antimicrobial activity, cytotoxicity assessment and ROS-inducing potential, Polymer (United Kingdom), 53, 2818, 10.1016/j.polymer.2012.04.057 · DOI
- Stevens, 2011, Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters, Biomaterials, 32, 1264, 10.1016/j.biomaterials.2010.10.042 · DOI
- Stobie, 2009, Silver doped perfluoropolyether-urethane coatings: antibacterial activity and surface analysis, Colloids Surf. B Biointerfaces, 72, 62, 10.1016/j.colsurfb.2009.03.014 · doi:10.1016/j.colsurfb.2009.03.014
- Strohal, 2005, Nanocrystalline silver dressings as an efficient anti-MRSA Barrier: a new solution to an increasing problem, J. Hosp. Infect., 60, 226, 10.1016/j.jhin.2005.04.001 · DOI
- Su, 2009, The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay, Biomaterials, 30, 5979, 10.1016/j.biomaterials.2009.07.030 · DOI · Paper page
- Su, 2011, Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria, PLoS One, 6, 1, 10.1371/journal.pone.0021125 · DOI
- Suleman, 2015, Silver salts of carboxylic acid terminated generation 1 poly(propyl ether imine) (PETIM) dendron and dendrimers as antimicrobial agents against S. Aureus and MRSA, RSC Adv., 5, 34967, 10.1039/C5RA03179F · DOI
- Suliman, 2013, Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells, Environ. Toxicol., 30, 149, 10.1002/tox.21880 · DOI
- Sung, 2009, Subchronic inhalation toxicity of silver nanoparticles, Toxicol. Sci., 108, 452, 10.1093/toxsci/kfn246 · DOI · Paper page
- Tang, 2009, Distribution, translocation and accumulation of silver nanoparticles in rats, J. Nanosci. Nanotechnol., 9, 4924, 10.1166/jnn.2009.1269 · DOI · Paper page
- Tang, 2015, Preparations of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells, J. Mater. Chem. B, 3, 6805, 10.1039/C5TB00912J · DOI
- Tsai, 2009, Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles, Lasers Surg. Med., 41, 316, 10.1002/lsm.20754 · DOI
- Tuchscherr, 2011, Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection, EMBO Mol. Med., 3, 129, 10.1002/emmm.201000115 · DOI · Paper page
- Turos, 2007, Penicillin-bound polyacrylate nanoparticles: restoring the activity of β-lactam antibiotics against MRSA, Bioorg. Med. Chem. Lett., 17, 3468, 10.1016/j.bmcl.2007.03.077 · DOI
- Turos, 2007, Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents, Bioorg. Med. Chem. Lett., 17, 53, 10.1016/j.bmcl.2006.09.098 · DOI · Paper page
- Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies, Chem. Rev., 116, 5338, 10.1021/acs.chemrev.5b00589 · DOI · Paper page
- Vanderesse, 2011, Nanoparticles for photodynamic therapy applications, 10.1007/978-94-007-1248-5_19 · DOI
- Vigderman, 2013, Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules, Adv. Drug Deliv. Rev., 65, 663, 10.1016/j.addr.2012.05.004 · DOI · Paper page
- Visage, 2001, Novel microparticulate system made of poly (methylidene malonate 2.1.2), Biomaterials, 22, 2229, 10.1016/S0142-9612(00)00411-7 · DOI
- Walsh, 2003, Where will new antibiotics come from, Nat. Rev. Microbiol., 1, 65, 10.1038/nrmicro727 · DOI · Paper page
- Walsh, 2004, A shot in the arm, Nature, 431, 892, 10.1038/431892a · DOI · Paper page
- Wang, 2011, Intra-discal vancomycin-loaded PLGA microsphere injection for MRSA discitis: an experimental study, Arch. Orthop. Trauma Surg., 131, 111, 10.1007/s00402-010-1154-8 · DOI
- Wang, 2015, Mesoporous silica nanoparticles in drug delivery and biomedical applications, Nanomed. Nanotech. Biol. Med., 11, 313, 10.1016/j.nano.2014.09.014 · DOI · Paper page
- Webster, 2006, Nanomedicine: what’s in a definition, Int. J. Nanomedicine, 1, 115, 10.2147/nano.2006.1.2.115 · doi:10.2147/nano.2006.1.2.115
- Williams, 1996, The glycopeptide story—how to kill the deadly “superbugs.”, 10.1039/NP9961300469 · DOI
- Wong, 2010, Silver nanoparticles—the real “silver bullet” in clinical medicine, Med. Chem. Comm., 1, 125, 10.1039/c0md00069h · DOI · Paper page
- Xu, 2006, Inorganic nanoparticles as carriers for efficient cellular delivery, Chem. Eng. Sci., 61, 1027, 10.1016/j.ces.2005.06.019 · DOI · Paper page
- Xue, 2015, Antimicrobial polymeric materials with quaternary ammonium and phosphonium salts, Int. J. Mol. Sci., 16, 3626, 10.3390/ijms16023626 · DOI · Paper page
- Yang, 2011, Antimicrobial peptide–modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy, Photochem. Photobiol. Sci., 10, 1593, 10.1039/c1pp05100h · DOI
- Yang, 2012, Wheat germ agglutinin modified liposomes for the photodynamic inactivation of bacteria, Photochem. Photobiol., 88, 548, 10.1111/j.1751-1097.2011.00983.x · DOI
- Yoshioka, 1981, Specific delivery of mitomycin C to the liver, spleen and lung: nano- and microspherical carriers of gelatin, Int. J. Pharm., 81, 131, 10.1016/0378-5173(81)90017-X · DOI
- You, 2014, Pharmacokinetics, clearance, and biosafety of polyethylene glycol–coated hollow gold nanospheres, 26
- Yu, 2007, Formation of colloidal silver nanoparticles stabilized by Na+-poly (γ-glutamic acid)–silver nitrate complex via chemical reduction process, Colloids Surf. B Biointerfaces, 59, 171, 10.1016/j.colsurfb.2007.05.007 · DOI · Paper page
200 of 204 shown
Cited by
Antimicrobial Nano-Agents: The Copper Age
Ermini, M. L., & Voliani, V. (2021) · ACS Nano · doi:10.1021/acsnano.0c10756 · Cited by 477
Hajimohammadi, S., Momtaz, H., & Tajbakhsh, E. (2024) · Veterinary Medicine and Science · doi:10.1002/vms3.1440 · Cited by 12
Metadata
- Authors
- Labruère, R., Sona, A. J., & Turos, E.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-10-04
- Volume
- 10
- ISSN
- 1663-9812
- Cited by
- 53
- References
- 11
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.